|4Feb 7, 4:44 PM ET

Molineaux Susan 4

4 · Cyteir Therapeutics, Inc. · Filed Feb 7, 2023

Insider Transaction Report

Form 4
Period: 2023-02-03
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-03+14,15014,150 total
    Exercise: $1.69Exp: 2033-02-03Common Stock (14,150 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying this stock option award vest in full on February 3, 2024, subject to the Reporting Person's continued service to the board of directors of the Company through the applicable vesting date.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT